During the CC Q&A Richard Chin mentioned that many companies have shown interest in "partnering" and that Kindred has that option if needed.
Richard mentioned they would be initiating more programs due to the IPO being so successful.
He also stated that they have enough money to last them become cash flow positive which will be in three years. Cheers
Sentiment: Strong Buy
Thanks for that update. Anything else of note? Any analyst questions and from whom? TIA
Management sounds very confident and I would expect results on Cerekin by June at the latest.
It seems the team they have assembled is exceptional.
We should hear within the next few weeks about Centikin in regard to initiating a pivotal study.
The expertise and the experience they have in developing and marketing Human/Animal medicines is remarkable.
Richard Chin continues to remind investors and analysts that we are in the very early stages of this market. So I fully expect Kindred to dominate due to their expertise and speed.
What I think many people are missing is how many catalysts there will be this year and next which should if the catalysts are positive maintain the momentum and create lots of attention.
This is a very long term holding with plenty of short term catalysts.
You should listen to the CC and judge for yourself.
Remember the IPO was only a few months ago and they are going to have a very impressive 2014
in regard to output.